Use of selective modulators of estrogen receptors in the treatment of menopausal symptoms
DOI:
https://doi.org/10.18370/2309-4117.2014.15.45-58Keywords:
menopause, selective estrogen receptor modulatorsAbstract
We evaluated the effectiveness of the drug Sahenit in women with climacteric syndrome of varying degrees of severity. Established that drug Sahenit is a selective estrogen receptor modulators that is highly effective in treatment of psycho-emotional and neurovegetative disorders in menopause. The lack of proliferative effect of the drug on the endometrium of the uterus enables its extensive use as an alternative to hormone replacement therapy in women in risk group and with complicated gynecological history.
References
- Zaydieva YZ New treatment options for menopausal symptoms in postmenopausal women // South-Russian Medical Journal. – 2003. – № 2. – P. 64 –70.
- Repina MA Problems of the menopausal transition: low-dose hormone replacement therapy with micronized estradiol combined with dydrogesterone // Farmateka. – 2008. – № 14. – P. 39 –44.
- Saidova RA, Aleksanyan SG, Tropynina EV Modern principles of hormonal correction of menstrual dysfunction in perimenopause // Questions of gynecology, obstetrics and perinatology. – 2008. – № 4, Vol. 7. – P. 46 –52.
- Smetnik VP, Tumilovich LG Biomedical problems of menopause and postovariectomy / In.: Non-surgery gynecology. M.: MIA 2003. – P. 458 –499.
- Studd J, Panay N Hormones and depression in women // Climacteric.–2004.– № 7.– Р. 344–347.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 О. В. Кравченко
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.